Home
Scholarly Works
Cost-effectiveness of gemcitabine in stage IV...
Journal article

Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: An estimate using the population health model lung cancer module

Authors

Evans WK

Journal

SEMINARS IN ONCOLOGY, Vol. 24, No. 2, pp. S56–S63

Publisher

W B SAUNDERS CO

Publication Date

April 1, 1997

ISSN

0093-7754

Labels

Fields of Research (FoR)

Contact the Experts team